REGULATORY AGENCY ACTION
use consultants and expert examiners to
assist it in conducting the examination
and to use exams given by other agencies
or organizations as a supplement to the
exam given by the Board. AB 2114 is a
two-year bill pending in the Senate Business and Professions Committee.
At its September meeting, the Board
decided to take no position on AB 2114
as amended. Board members expressed
confusion as to the consequences of the
bill; the Board believes it is already free
to accept the advice of consultants in
preparing and administering its exam,
and expressed concern about the possibility that this bill would curtail that
authority.
AB 2198 (Klehs) would require the
Board to administer its licensing exam
at least twice per year; increase the maximum amount of the application fee from
$75 to $195; and increase the maximum
refund to those found ineligible to take
the exam from $50 to $150. At its September meeting, the Board expressed
concern about this bill, claiming that it
is understaffed to administer even one
exam per year. Even with additional
funding for a half-time employee, the
Board does not feel it has the resources
to offer two exams at this time. AB
2198 is a two-year bill pending in the
Senate Business and Professions Committee.
The following bills, which were discussed in detail in CRLR Vol. 9, No. 3
(Summer 1989) at page 65, were made
two-year bills, and may be pursued when
the legislature reconvenes in January:
AB 881 (Hughes), which would authorize the Board to require proof of completion of continuing education as a
condition for license renewal; AB 1807
(Statham), which would authorize optometrists having experience equivalent
to specified educational and examination
requirements to be permitted the use of
pharmaceutical agents; SB 929 (Seymour), which would prohibit licensees
from dispensing or selling contact lenses
unless the licensee or his/her authorized
agent has first determined the proper fit
of the lenses by fitting the generic type
of lenses to the person named in the
prescription; and SB 1104 (Roberti),
which would extend until January I,
1992, the Board's authority to refuse to
honor optometry degrees awarded by
foreign universities if the Board finds
the curriculum to be less than that required in the United States.
RECENT MEETINGS:
The Board's August 30-31 meeting
was a "retreat" meeting which included
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discussions of internal structure, strategic
planning, and goal-setting. The Board
verbalized its mission statement as "protection of the California consumer by
regulating the practice of optometry in
accordance with California law." The
goals set by the Board include the following: to complete the agenda at all
Board meetings; resolve the foreign graduate Iicensure problem; periodically
assess and evaluate Board members, the
Executive Officer, and Board staff; codify
policy and procedures; establish incoming and outgoing Board member procedures; and revise and delete obsolete
forms and applications. The Board established special committees to implement
these goals.
At its September 20 meeting, Board
members spent a considerable amount
of time trying to "correct" the minutes
of the March and August meetings.
Board legal counsel Bob Miller advised
that it is acceptable to draft "action
minutes" as opposed to the more informative narrative minutes the Board has
kept in the past. Board President Julia
Preisig stated that the Board prefers the
narrative format, so members can refer
to earlier reasoning and decisions and
avoid rehashing the same issues in future
meetings.
The Board also heard a report by
former Board member and immediate
past president, Dr. Larry Thal, on the
possibility of California optometrists
using therapeutic drugs in the future.
Dr. Thal summarized his studies but
declined to give any recommendation.
He cited cost containment, better quality
care, and improved access to care as the
advantages to consumers. He opined that
with 160 hours of ocular pharmacology
in their training, optometrists are better
trained in this area than any other health
care provider. He also stated his belief
that optometrists have proven their ability to diagnose and that, in terms of risk
to the patient, diagnostic drugs are far
more toxic than therapeutic drugs. He
suggested that in considering whether to
support therapeutics legislation, the
Board should carefully review the scope
of the proposed therapeutic licensure to
make sure that it is appropriate; he also
cautioned that grandfathering should not
be allowed. The Board decided to put
his research materials and report on file
at its office for future reference.
FUTURE MEETINGS:
To be announced.

BUREAU OF PERSONNEL
SERVICES
Chief- Janelle Wedge
(916) 920-63JJ
The Bureau of Personnel Services
was established within the Department
of Consumer Affairs (DCA) to regulate
those businesses which secure employment or engagements for others for a
fee. The Bureau regulates both employment agencies and nurses' registries.
Businesses which place applicants in
temporary positions or positions which
command annual gross salaries in excess
of $25,000 are exempt from Bureau regulation; similarly, employer-retained
agencies are also exempt from Bureau
oversight.
The Bureau's primary objective is to
limit abuses among those firms which
place individuals in a variety of employment positions. It prepares and administers a licensing examination and issues
several types of licenses upon fulfillment
of the Bureau's requirements. Approximately 900 agencies are now licensed by
the Bureau.
The Bureau is assisted by an Advisory
Board created by the Employment Agency Act. This seven-member Board consists of three representatives from the
employment agency industry and four
public members. All members are appointed for a term of four years. As of this
writing, seats for one public and two
industry members remain vacant.
LEGISLATION:
The following is a status update on
bills described in detail in CRLR Vol. 9,
No. 3 (Summer 1989) at page 66:
AB 2113 (Johnson), entitled the "Employment Agency, Employment Counseling, Job Listings Services Act," repeals
the entire Employment Agency Act in
the Business and Professions Code, existing provisions of law which create the
Bureau of Personnel Services and provide for its funding, examining, licensing,
and regulatory functions, and those provisions which provide for nurses' registries and prepaid computer employment
agencies and job listing services. The bill
reenacts certain provisions of the Employment Agency Act as part of the Civil
Code so that the contents of employment
agency, employment counseling service,
and job listing service contracts, and the
advertising and fees of such agencies,
are regulated by statute in lieu of the
Bureau. The bill's August 25 amendments
appropriate any funds remaining in the
Bureau of Personnel Services Fund to
the Department of Consumer Affairs
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for specified purposes of the act. This
bill, which takes effect on January I,
1990, was signed by the Governor on
September 22 (Chapter 704, Statutes of
1989).
AB 2469 (Johnston), as amended July
18, continues the present deregulation
of employer-paid agencies which occurred under AB 2929 beyond the January
I, 1991 sunset date. Although this bill
was signed by the Governor on September 22 (Chapter 705, Statutes of 1989), a
provision in the bill states that it will
not become operative if AB 2113 is chaptered and takes effect on or before January I, 1990.
SB 1673 (Montoya), which would
add an applicant's complaint history to
the Bureau's criteria for evaluating possible restrictions on an applicant's license, is a two-year bill pending in the
Senate Business and Professions Committee.

BOARD OF PHARMACY
Executive Officer: Lorie G. Rice
(916) 445-5014
The Board of Pharmacy grants licenses and permits to pharmacists, pharmacies, drug manufacturers, wholesalers
and sellers of hypodermic needles. It
regulates all sales of dangerous drugs,
controlled substances and poisons. To
enforce its regulations, the Board employs full-time inspectors who investigate
accusations and complaints received by
the Board. Investigations may be conducted openly or covertly as the situation
demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized
by law to suspend or revoke licenses or
permits for a variety of reasons, including professional misconduct and any acts
substantially related to the practice of
pharmacy.
The Board consists of ten members,
three of whom are public. The remaining
members are pharmacists, five of whom
must be active practitioners. All are appointed for four-year terms.
MAJOR PROJECTS:
Regulatory Changes. Following a
May regulatory hearing, the Board adopted several changes to its regulations at
its July meeting. (See CRLR Vol. 9, No.
3 (Summer 1989) p. 67 for background
information on these changes.) The
Board adopted a slightly modified version of section 1710, Chapter 17, Title
16 of the California Code of Regulations
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(CCR), to define an inpatient hospital
pharmacy as one which, although predominantly serving inpatients of that
hospital, may furnish drugs to outpatients or employees, provided that
sales to walk-in customers do not exceed
1% of all the pharmacy's prescriptions.
The Board also adopted an amendment to section 1707.1, to require pharmacists to orally consult with the patient
whenever a prescription drug is dispensed
for the first time. Finally, the Board
amended section I 717(c), to specify the
tasks which may be performed by an
unlicensed person under the supervision
of a licensed pharmacist.
The Board received over 300 comments on these proposed regulations,
and is currently preparing the rulemaking record on all three changes for
submission to the Office of Administrative Law (OAL).
English Proficiency Examination.
After a July 25 hearing, the Board approved a proposed amendment to section
1719 of its regulations. (See CRLR Vol.
9, No. 3 (Summer 1989) p. 67 for background information.) The revised version
states that candidates for licensure who
have been non-U.S. residents for more
than ten years must take and pass the
Test of Spoken English in addition to
satisfying all other licensure requirements. The Board is preparing the rulemaking file for submission to OAL.
Foreign Graduates. The Board was
scheduled to hold a regulatory hearing on
October 25 on several proposed changes
affecting the licensure of foreign graduates.
Business and Professions Code section 4085(b)(2) requires an applicant for
the Board's exam who has graduated
from a foreign pharmacy school to
demonstrate that his/ her education is
equivalent to that of domestic graduates,
or take an equivalency examination. The
proposed adoption of new section 1720.1,
Chapter 17, Title 16 of the CCR, would
set forth the acceptable method of
demonstrating curriculum equivalency.
The Board would delegate the task of
performing equivalency evaluations to
the Credentials Evaluation Service
(CES), an established national organization used by other licensing boards and
which is approved by the American Council on Pharmaceutical Education. The
new section would also specify that the
acceptable equivalency examination is
the Foreign Pharmacy Graduate Equivalency Examination (FPGEE) administered by the National Association of
Boards of Pharmacy.
The Board also plans to amend section I 720 in several ways: first, it would
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add subsection (d) to set a five-year
limit (from the time of receipt of the
application for evaluation to the time
when one would apply for the licensure
examination) as the maximum time to
complete the evaluation process, after
which the application will be deemed
abandoned. New subsection (c) would
specify that the file of an applicant who
fails to pay the licensing fee for a twoyear period after passing the examination
will be deemed abandoned. Finally, the
Board plans to make technical changes
to section I 720(b).
"Black Bag" Regulation. Also on
October 25, the Board was scheduled to
hold a hearing on the proposed addition
of new section 1751.10 to its regulations.
This section would allow a pharmacist
to carry and furnish, to a patient at
home, dangerous drugs (except controlled substances) and devices for parenteral
therapy (the intravenous administration
of medication) when the dangerous drug
or device is one currently prescribed for
the patient, and the prescription has not
been superseded by a different drug or
device.
Attorney General's Opinion. Pursuant to a request by the Board, the Attorney General recently issued an opinion
on whether the Board of Pharmacy has
jurisdiction over pharmaceutical facilities
on the campuses of the University of
California. The AG's July 6 opinion
(No. 89-402) held that "a pharmacy operated by the University of California is
subject to the licensure, inspection and
disciplinary provisions of the Pharmacy
Law."
LEGISLATION:
SB 802 (Marks) expressly prohibits
a residential care facility for the elderly
from requiring patients to purchase drugs,
or rent or purchase medical equipment
from any particular pharmacy or other
source. This bill was signed by the Governor on October 2 (Chapter 1419, Statutes of 1989).
AB 2083 (Polanco), as amended
August 31, would have prohibited the
retail sale of Syrup of Ipecac unless it is
furnished by the retailer from supplies
not accessible to the public and in response to a request by the purchaser.
This bill was vetoed by the Governor on
September 21.
AB 1932 (Polanco) would provide
that any person who knowingly sells
Syrup of Ipecac, any laxative, or any
diuretic to another person who is under
the age of eighteen years is subject to
either criminal action for a misdemeanor
or a civil action brought by a city attor-
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